CTxB binds with high affinity to GM1, a glycosphingolipid enriched in lipid rafts . This interaction initiates:
Membrane Reorganization: Clustering of GM1 induces phase separation, stabilizes ordered lipid domains (rafts), and generates membrane curvature .
Endocytosis: CTxB-GM1 complexes enter cells via clathrin-dependent, caveolin-dependent, or clathrin-independent pathways (e.g., CLIC/GEEC) .
After internalization, CTxB undergoes retrograde transport to the endoplasmic reticulum (ER), enabling CTA’s cytosolic entry and ADP-ribosylation of Gαs . Trafficking kinetics depend on GM1’s ceramide structure .
CTxB triggers MAPK/NFκB signaling, promoting anti-inflammatory responses. This property underpins its use as a vaccine adjuvant .
CTxB generates negative membrane curvature via cooperative GM1 clustering. Simulations show this process involves:
CTxB preferentially binds GM1 in liquid-ordered (Lo) membrane phases, but molecular dynamics simulations suggest stronger hydrogen bonding in liquid-disordered (Ld) environments . Experimental data confirm rapid Lo-phase localization in GUVs and GPMVs .
The H57A mutant retains GM1 binding but loses toxicity and immunomodulatory activity. Structural analysis reveals a 7-Å loop displacement occluding the central pore, disrupting interactions essential for cellular entry .
Membrane Raft Marker: CTxB stabilizes GM1-rich nanodomains, though it actively modifies membrane organization rather than passively labeling rafts .
Curvature Sensor: Used to study membrane tubulation and endocytic carrier formation .
Vaccine Adjuvant: Enhances antigen uptake and immune responses .
Autoimmune Therapy: Suppresses proinflammatory pathways via GM1-mediated signaling .
Cholera Toxin B subunit (ctxB), produced by the bacterium Vibrio cholerae, is the protein complex responsible for the severe watery diarrhea associated with cholera infection. This toxin comprises six protein subunits: one A subunit and five B subunits, forming an AB5 structure. The B subunit binds to target cells, while the A subunit activates a G protein, which in turn activates adenylate cyclase. Five B subunits arrange themselves in a ring, with the A subunit's A1 portion (CTA1) acting as an enzyme that modifies G proteins and the A2 chain (CTA2) forming a helix nestled within the B subunit ring's central pore.
Recombinant Cholera Toxin B subunit, produced in E. coli, is a single, non-glycosylated polypeptide chain with 103 amino acids and a molecular weight of 11.6 kDa. This ctxB product is purified using proprietary chromatographic techniques.
A sterile, colorless solution.
ctxB is provided in a 0.2 µm filtered solution containing 5mM PB (pH 7.0), 75mM NaCl, and 50% glycerol.
For short-term storage (up to 2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity exceeds 98.0%, as determined by: (a) RP-HPLC analysis and (b) SDS-PAGE analysis.
Cholera enterotoxin subunit B, Cholera enterotoxin B chain, Cholera enterotoxin gamma chain, Choleragenoid, ctxB, toxB.
Escherichia Coli.
TPQNITDLCA EYHNTQIYTL NDKIFSYTES LAGKREMAII TFKNGAIFQV EVPGSQHIDS QKKAIERMKD TLRIAYLTEA KVEKLCVWNN KTPHAIAAIS MAN.
ctxB encodes the B-subunit of cholera toxin (CTxB) in Vibrio cholerae. The toxin consists of one A-subunit (encoded by ctxA) and five identical B-subunits that form a pentameric ring. This structure is essential for the pathogenesis of cholera, as CTxB binds to GM1 gangliosides on intestinal epithelial cells, allowing the A-subunit to enter cells and activate adenylate cyclase. This activation leads to massive fluid secretion into the intestinal lumen, causing the profuse watery diarrhea characteristic of cholera .
CTxB is not merely a passive membrane binder but actively modifies membrane properties. Research has shown that CTxB can drive phase separation, induce membrane curvature, stabilize lipid rafts, stimulate its own internalization, and redirect GM1 into different intracellular trafficking pathways. These activities depend on CTxB's ability to bind multiple GM1 molecules simultaneously. Studies demonstrate that CTxB requires binding to at least two GM1 molecules to generate membrane curvature, as confirmed by comparing pentavalent wild-type CTxB with monovalent mutant CTxB that can bind only a single GM1 .
The membrane-modifying abilities of CTxB stem from several key structural features:
Its homopentameric structure with five identical subunits arranged in a ring
GM1 binding pockets located on the perimeter of the pentamer
Binding pockets elevated above the membrane-binding surface
Several PCR-based methods have been optimized for ctxB analysis:
Conventional PCR Protocol:
Reaction mixture (25 μL total):
DNA template (100 ng): 1 μL
Forward primer (10 pmol): 1 μL
Reverse primer (10 pmol): 1 μL
Master mix (2X): 12.5 μL
Deionized water: 7 μL
Cycling conditions:
Real-Time PCR Protocol:
Reaction mixture (25 μL total):
2x Real-Time probe master with ROX: 12.5 μL
Forward/reverse primers (10 pmol each): 1 μL each
Dual-labeled DNA probe (10 pM): 2 μL
DNA template (100 ng): 2.5 μL
PCR-grade water: 6 μL
Cycling conditions:
Double Mismatch Amplification Mutation (DMAMA) PCR is particularly useful for detecting specific ctxB genotypes based on known mutations, using primers with deliberate mismatches near the 3' end to selectively amplify specific alleles .
HRM analysis has emerged as a powerful technique for studying ctxB mutations because it's simple, fast, and sensitive. The method works through:
PCR amplification using a saturating fluorescent dye (e.g., HOT FIREPol® EvaGreen®)
Gradually melting the PCR product from 75°C to 95°C in 0.1°C increments
Continuously monitoring fluorescence changes during melting
Analyzing melting curve shapes, which differ between variants due to:
GC content variations
Sequence length differences
Nucleotide substitutions
Heterozygosity
Research demonstrates that HRM is particularly valuable for monitoring toxigenic V. cholerae strains during outbreaks, as it can rapidly identify genetic modifications without requiring subsequent probing or sequencing. This makes it a sensitive, cost-effective tool for differentiating between different ctxB variants in clinical settings .
For comprehensive analysis of ctxB genetic diversity, several sequencing approaches have proven effective:
Direct Sequencing of PCR Products:
Amplify ctxB gene fragments by PCR
Sequence each amplified fragment multiple times (3×) for verification
Analyze sequences using software like Chromas to identify variations
Comparative Sequence Analysis:
Align sequences from different strains
Identify single nucleotide polymorphisms (SNPs)
Detect insertions/deletions and changes in regulatory regions
Perform phylogenetic analyses to understand evolutionary relationships
Whole Genome Sequencing:
Provides comprehensive genetic context of ctxB
Enables identification of all genetic variations
Allows analysis of relationships between ctxB and other virulence genes
Most valuable for evolutionary studies and outbreak investigations
The choice of sequencing approach depends on research objectives, with targeted sequencing being more cost-effective for routine surveillance and whole genome sequencing providing deeper insights for evolutionary studies.
Genetic exchanges between Classical and El Tor biotypes create hybrid strains with altered virulence properties. These exchanges affect ctxB expression and function in several ways:
Promoter Structure Differences:
Classical and El Tor ctxAB promoters differ in the number of heptad TTTTGAT repeats in their upstream regions, which affects transcriptional regulation .
Regulatory Mechanisms:
In Classical biotype, ToxRS can directly activate ctxAB expression in a ToxT-independent manner when bile acids are present. This direct activation isn't observed in El Tor strains due to promoter differences. When genetic exchanges occur, these regulatory mechanisms can be altered, potentially changing toxin expression patterns .
Virulence Consequences:
Hybrid strains may combine advantageous traits from both parental biotypes, such as efficient colonization (El Tor) with higher toxin production (Classical). Research has shown that changes in ctxB sequences facilitate genetic exchanges between strains, potentially creating variants with enhanced virulence that contribute to recent outbreaks .
ToxR plays a sophisticated role in regulating ctxB expression in response to environmental cues:
Dual Regulatory Pathways:
ToxR can regulate ctxAB through two distinct mechanisms:
Indirectly through the ToxR→ToxT regulatory cascade (primary pathway)
Directly activating ctxAB in a ToxT-independent manner (in Classical biotype)
Bile Acid Sensing:
The direct activation pathway is particularly interesting as it requires bile acids, which are present in the human intestinal environment. The transmembrane domain of ToxR appears to interact with bile acids in the inner membrane of V. cholerae, creating a physiological sensing system independent of pH and temperature .
Biotype-Specific Effects:
Classical biotype V. cholerae shows bile acid-stimulated, ToxRS-dependent expression of cholera toxin. This stimulation is not observed in El Tor biotype strains due to differences in their ctxAB promoters. This biotype-specific response to bile acids may contribute to differences in virulence and adaptation to the host environment .
This environmental sensing mechanism likely plays an important role during natural infection, as bile acids are abundant in the human intestine where V. cholerae causes disease.
The evolution of ctxB variants has significantly shaped cholera epidemiology:
Emergence of Hybrid Strains:
Classical ctxB genes have been detected in El Tor biotype strains, creating hybrid variants that combine advantageous properties from both biotypes. These strains have been implicated in more severe outbreaks and changing epidemiological patterns.
Sequential Outbreaks with Mixed Alleles:
Studies have documented sequential outbreaks caused by V. cholerae strains with different ctxB alleles. For example, in Mayurbhanj district of Odisha, India, sequential outbreaks were attributed to V. cholerae O1 strains with varied ctxB genotypes .
Genetic Diversity and Virulence:
Changes in ctxB sequences facilitate genetic exchanges between strains, potentially creating new variants with enhanced virulence or transmission capabilities. Recent research indicates that various sequences of ctxB in different V. cholerae strains contain changes that enable genetic exchanges, potentially creating more virulent strains .
Monitoring ctxB diversity has become essential for predicting outbreak potential and understanding the continued evolution of V. cholerae strains with altered epidemiological characteristics.
Understanding the relationship between ctxB genotypes and clinical outcomes requires:
Integrated Analysis Approach:
Collecting clinical data on symptom severity, treatment response, and outcomes
Isolating and genotyping V. cholerae strains from patients
Sequencing ctxB and analyzing genetic variations
Performing statistical analyses to identify correlations
Observed Patterns:
Classical ctxB variants typically produce more toxin than El Tor variants
Hybrid strains with Classical ctxB in an El Tor background often cause more severe disease
Sequential outbreaks in specific regions have been linked to shifts in predominant ctxB variants
Research Application:
This correlation analysis can inform treatment strategies, predict outbreak severity, and guide public health interventions during cholera epidemics.
Effective molecular surveillance of ctxB variants requires a multi-tiered approach:
Method | Speed | Cost | Resolution | Application |
---|---|---|---|---|
Conventional PCR | High | Low | Low | Initial screening |
Real-time PCR | High | Medium | Medium | Quantitative analysis |
HRM Analysis | High | Low | Medium | Mutation screening |
DMAMA PCR | High | Low | Medium | Specific genotyping |
Sequencing | Medium | Medium | High | Detailed analysis |
PFGE | Low | Medium | Medium | Clonality analysis |
WGS | Low | High | Very High | Comprehensive analysis |
An optimal surveillance protocol might include:
Initial screening with conventional or real-time PCR
Rapid variant discrimination using HRM analysis
Detailed characterization of selected isolates by sequencing
Periodic whole genome sequencing to detect emerging variants
Research has demonstrated that HRM analysis is particularly valuable for surveillance because it rapidly detects genetic modifications in ctxB without requiring subsequent probing or sequencing .
Integrating antibiotic resistance data with ctxB analysis provides valuable epidemiological insights:
Methodological Approach:
Isolate V. cholerae from clinical samples
Determine antibiotic susceptibility profiles using standardized methods
Identify ctxB variants through PCR, sequencing, or HRM analysis
Detect specific resistance genes through multiplex PCR
Analyze correlations between ctxB variants and resistance patterns
Research Findings:
Studies have identified associations between specific ctxB variants and antibiotic resistance profiles. For example, in Mayurbhanj district outbreaks, V. cholerae O1 Ogawa biotype El Tor strains with particular ctxB variants showed resistance to co-trimoxazole, nalidixic acid, nitrofurantoin, and streptomycin .
Applications:
Understanding these associations can:
Help predict resistance patterns based on circulating ctxB variants
Inform appropriate antibiotic selection for treatment
Track the co-evolution of virulence and resistance determinants
Guide public health interventions during outbreaks
Cholera toxin (CT) is a protein complex secreted by the bacterium Vibrio cholerae, the causative agent of cholera. The toxin is composed of two subunits: A and B. The B subunit (CTB) is responsible for binding to the host cell surface, facilitating the entry of the A subunit, which then exerts the toxic effects. Recombinant Cholera Toxin B subunit (rCTB) is a genetically engineered version of the CTB, produced without the toxic A subunit, making it a valuable tool in research and therapeutic applications.
The CTB subunit is a pentameric protein, meaning it forms a complex of five identical subunits. Each subunit binds to the GM1 ganglioside, a glycolipid found on the surface of mammalian cells. This binding is crucial for the toxin’s entry into the cells. The recombinant version of CTB retains this binding ability, allowing it to be used in various applications without the associated toxicity of the A subunit .
Recombinant CTB is typically produced in bacterial or mammalian expression systems. One common method involves expressing the protein in Escherichia coli or HEK 293 cells. The recombinant protein is then purified using affinity chromatography techniques, ensuring high purity and the absence of the toxic A subunit .